timolol maleate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
VIZO-PF DORZOLATIM dorzolamide (as hydrochloride) 20 mg/mL and timolol (as maleate) 5 mg/mL eye drop solution multi-dose bottle
AUST R: 341770
Active ingredients:
dorzolamide hydrochloride
timolol maleate

Dosage form:
Eye Drops, solution

Sponsor:
AFT Pharmaceuticals Pty Ltd

Phone:
02 94200420

From
30 Apr 2025
to
31 Jul 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Alternative generic product is available.

TIMOPTOL timolol maleate 0.5% eye drops bottle
AUST R: 28775
Active ingredients:
timolol maleate

Dosage form:
Eye Drops, solution

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

From
29 Nov 2024
to
27 May 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Commercial Changes / Commercial viability

TIMOPTOL-XE timolol 5mg/mL (as maleate) eye drops bottle
AUST R: 50306
Active ingredients:
timolol maleate

Dosage form:
Eye Drops, solution

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

From
12 Aug 2024
to
11 Jun 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Commercial Changes / Commercial viability

COSOPT PRESERVATIVE-FREE dorzolamide (as hydrochloride) 20mg/mL and timolol (as maleate) 5mg/mL single dose eye drop ampoule
AUST R: 165915
Active ingredients:
dorzolamide hydrochloride
timolol maleate

Dosage form:
Eye Drops, solution

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

Deletion from market:
31 Jul 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative generic product is available.